Dendritic amphiphilic siRNA: Selective albumin binding, in vivo efficacy, and low toxicity is a research paper published in Molecular Therapy — Nucleic Acids (2023). On theSindex it has a DataRank of 0. It has been cited 20 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH HHS
Grant: S10 OD020012
NINDS NIH HHS
Grant: R01 NS111990
NIGMS NIH HHS
Grant: R35 GM131839
Natural Sciences and Engineering Research Council of Canada
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01NS111990-03
Next-generation antisense therapeutics for ALS and frontotemporal dementia
National Institutes of Health
Grant: 1S10OD020012-01
Mid-Scale RNA Synthesis, Purification and Quality Control System
Canada Foundation for Innovation
Canada Research Chairs Program
Aldeyra Therapeutics
Fonds de recherche du Quebec
National Institute of General Medical Sciences
Natural Sciences and Engineering Research Council of Canada
National Institutes of Health
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals